A J Brown

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. ncbi The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells
    Alex J Brown
    Renal Division, Washington University School of Medicine, St Louis, MO 63110, USA
    Nephrol Dial Transplant 21:644-50. 2006
  2. ncbi Vitamin D analogues for secondary hyperparathyroidism
    Alex J Brown
    Renal Division, Washington University School of Medicine, St Louis, Missouri, USA
    Nephrol Dial Transplant 17:10-9. 2002
  3. ncbi Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism
    Alex J Brown
    Renal Division, Washington University School of Medicine, St Louis, Missouri, USA
    Treat Endocrinol 1:313-27. 2002
  4. ncbi Therapeutic uses of vitamin D analogues
    A J Brown
    Renal Division, Washington University School of Medicine, St Louis, MO, USA
    Am J Kidney Dis 38:S3-S19. 2001
  5. ncbi Calcemic activity of 19-Nor-1,25(OH)(2)D(2) decreases with duration of treatment
    A J Brown
    Renal Division, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Am Soc Nephrol 11:2088-94. 2000
  6. ncbi Mechanisms for the selective actions of vitamin D analogues
    A J Brown
    Renal Division, Washington University School of Medicine, St Louis, MO 63110, USA
    Curr Pharm Des 6:701-16. 2000
  7. ncbi Vitamin D analogs: perspectives for treatment
    A J Brown
    Renal Division, Washington University School of Medicine, St Louis, MO 63110, USA
    Miner Electrolyte Metab 25:337-41. 1999
  8. ncbi Vitamin D
    A J Brown
    Renal Division, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Am J Physiol 277:F157-75. 1999
  9. ncbi Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate
    A J Brown
    Renal Division, Washington University Medical School, St Louis, Missouri, USA
    Kidney Int 55:1284-92. 1999
  10. ncbi Vitamin D analogues
    A J Brown
    Renal Division, Washington University School of Medicine, St Louis, MO 63110, USA
    Am J Kidney Dis 32:S25-39. 1998

Collaborators

Detail Information

Publications36

  1. ncbi The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells
    Alex J Brown
    Renal Division, Washington University School of Medicine, St Louis, MO 63110, USA
    Nephrol Dial Transplant 21:644-50. 2006
    ..In previous studies, 1alpha(OH)D3, a vitamin D prodrug, inhibited PTH secretion in cultured bovine parathyroid cells, but it was unclear whether 1alpha(OH)D3 itself or an active metabolite produced this inhibition...
  2. ncbi Vitamin D analogues for secondary hyperparathyroidism
    Alex J Brown
    Renal Division, Washington University School of Medicine, St Louis, Missouri, USA
    Nephrol Dial Transplant 17:10-9. 2002
    ..A clear understanding of the molecular basis for the selectivity of vitamin D analogues on parathyroid function may allow the design of even more effective analogues...
  3. ncbi Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism
    Alex J Brown
    Renal Division, Washington University School of Medicine, St Louis, Missouri, USA
    Treat Endocrinol 1:313-27. 2002
    ..The selectivity of the other analogs is achieved by distinct mechanisms. Understanding how these compounds exert their selective actions on the parathyroid glands will aid in the design of safer, more effective analogs...
  4. ncbi Therapeutic uses of vitamin D analogues
    A J Brown
    Renal Division, Washington University School of Medicine, St Louis, MO, USA
    Am J Kidney Dis 38:S3-S19. 2001
    ..Understanding how analogues exert their selective actions may allow for the design of more effective and safer vitamin D compounds for the treatment of a wide range of clinical disorders...
  5. ncbi Calcemic activity of 19-Nor-1,25(OH)(2)D(2) decreases with duration of treatment
    A J Brown
    Renal Division, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Am Soc Nephrol 11:2088-94. 2000
    ..In conclusion, the low calcemic activity of 19-norD(2) seems to be due to an acquired, postreceptor resistance of the intestine and bone to chronic treatment with the analog...
  6. ncbi Mechanisms for the selective actions of vitamin D analogues
    A J Brown
    Renal Division, Washington University School of Medicine, St Louis, MO 63110, USA
    Curr Pharm Des 6:701-16. 2000
    ..A thorough understanding of the influence of these analog/protein interactions on the biological profile of vitamin D analogs will be invaluable for the design of future analogs with enhanced target specificity...
  7. ncbi Vitamin D analogs: perspectives for treatment
    A J Brown
    Renal Division, Washington University School of Medicine, St Louis, MO 63110, USA
    Miner Electrolyte Metab 25:337-41. 1999
    ..Knowledge of how these compounds exert their selective actions on the parathyroid glands may allow the design of more effective analogs in the future...
  8. ncbi Vitamin D
    A J Brown
    Renal Division, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Am J Physiol 277:F157-75. 1999
    ..However, 1,25(OH)(2)D(3) can control the expression of many genes involved in a plethora of biological actions. Many of these nonclassic responses have suggested a number of therapeutic applications for 1,25(OH)(2)D(3) and its analogs...
  9. ncbi Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate
    A J Brown
    Renal Division, Washington University Medical School, St Louis, Missouri, USA
    Kidney Int 55:1284-92. 1999
    ..The cause of this down-regulation is unknown. Here we examined the roles of uremia and parathyroid hyperplasia on parathyroid gland (PTG) CaR expression in the rat model of renal failure...
  10. ncbi Vitamin D analogues
    A J Brown
    Renal Division, Washington University School of Medicine, St Louis, MO 63110, USA
    Am J Kidney Dis 32:S25-39. 1998
    ..Understanding of the molecular basis for the selectivity of the vitamin D analogues will allow the design of more effective and safer vitamin D compounds for the treatment of a wide range of clinical disorders...
  11. ncbi Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport
    Alex J Brown
    Renal Division, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Lab Clin Med 139:279-84. 2002
    ..In summary, the reduced calcemic and phosphatemic activities of 19-norD(2) can be attributed to lower potency in stimulating intestinal calcium and phosphate absorption...
  12. ncbi Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor
    C S Ritter
    Renal Division, Washington University Medical School, St. Louis, Missouri 63110, USA
    Kidney Int 60:1737-44. 2001
    ..CONCLUSION: These data indicate that parathyroid cell hyperplasia precedes down-regulation of CaR expression in the uremic rat model...
  13. ncbi 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells
    C S Ritter
    Renal Division, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Kidney Int 70:654-9. 2006
    ..Clotrimazole enhanced 24-hydroxylase mRNA induction, presumably by inhibiting catabolism of 25(OH)D(3). In conclusion, 25(OH)D(3) suppresses PTH synthesis by parathyroid cells, possibly by direct activation of the VDR...
  14. ncbi p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth
    A S Dusso
    Renal Division, Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Kidney Int 59:855-65. 2001
    ..In addition to reducing p21, high P-induced PT growth could result from increased PT expression of the growth promoter transforming growth factor-alpha (TGF-alpha), known to be elevated in hyperplastic and adenomatous human PT glands...
  15. ncbi The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure
    E Slatopolsky
    Department of Internal Medicine, Washington University, St Louis, Missouri, USA
    Am J Med Sci 317:370-6. 1999
    ..Unfortunately, the absence of a parathyroid cell line is slowing the progress in understanding the molecular mechanism(s) involved in phosphorus regulation of PTH...
  16. ncbi Mechanism of vitamin D action and its regulation
    A S Dusso
    Renal Division, Washington University School of Medicine, St Louis, MO 63110, USA
    Am J Kidney Dis 32:S13-24. 1998
    ..This section discusses the molecular mechanisms involved in the transcriptional control of gene expression by 1,25(OH)2D3...
  17. ncbi Parathyroid hormone stimulation of the renal 25-hydroxyvitamin D-1alpha-hydroxylase--effect of age and free radicals
    H J Armbrecht
    Geriatric Research, Education, and Clinical Center, St Louis VA Medical Center, St Louis, MO 63125, USA
    J Steroid Biochem Mol Biol 103:330-3. 2007
    ..This suggests that the catalytic activity of the CYP1alpha protein may be reduced by free radical damage in these cells. Future studies will focus on detecting oxidative damage in this model system and in vivo...
  18. ncbi Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism
    Eduardo Slatopolsky
    Renal Division, Washington University Medical School, St Louis, MO 63110, USA
    J Bone Miner Res 22:686-94. 2007
    ..We tested a new analog of vitamin D, 2MbisP, and found that it suppresses PTH at doses that do not affect serum Ca or P...
  19. ncbi Vitamin D analogs for secondary hyperparathyroidism: what does the future hold?
    Alex J Brown
    Renal Division, Washington University School of Medicine, Box 8126, 660 S Euclid, St Louis, MO 63110, USA
    J Steroid Biochem Mol Biol 103:578-83. 2007
    ..Combining these agents with higher doses of vitamin D compounds may achieve greater suppression of PTH and possibly enhance survival in patients with chronic kidney disease...
  20. ncbi Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease
    Alex J Brown
    Renal Division, Washington University School of Medicine, St Louis, MO, USA
    Nat Clin Pract Endocrinol Metab 3:134-44. 2007
    ....
  21. ncbi Vitamin D analogs: therapeutic applications and mechanisms for selectivity
    Alex J Brown
    Renal Division, Washington University School of Medicine, St Louis, MO 63110, USA
    Mol Aspects Med 29:433-52. 2008
    ..Although many new analogs show tremendous promise in cell-based models, this article will limit it focus on the development of analogs currently in use and those that have demonstrated efficacy in animal models or in clinical trials...
  22. ncbi Vitamin D analogs for the treatment of secondary hyperparathyroidism
    Eduardo Slatopolsky
    Washington University School of Medicine, Renal Division, St Louis, MO 63110, USA
    Blood Purif 20:109-12. 2002
    ..The lower Ca x P product in 19-nor-1,25(OH)(2)D(2)-treated rats may be an important consideration in patient therapy. Further studies in patients are necessary to define these differences...
  23. ncbi Destabilization of parathyroid hormone mRNA by extracellular Ca2+ and the calcimimetic R-568 in parathyroid cells: role of cytosolic Ca and requirement for gene transcription
    Cynthia S Ritter
    Renal Division, Washington University Medical School, Box 8126, 660 S Euclid, St Louis, Missouri 63110, USA
    J Mol Endocrinol 40:13-21. 2008
    ..However, increasing cytosolic Ca with thapsigargin or the Ca ionophore A23187 decreased PTH mRNA levels. In summary, Ca-mediated destabilization of PTH mRNA requires gene transcription and involves increases in cytosolic Ca...
  24. ncbi Effect of age, vitamin D, and calcium on the regulation of rat intestinal epithelial calcium channels
    Alex J Brown
    Renal Division, Washington University School of Medicine, St. Louis, MO 63110, USA
    Arch Biochem Biophys 437:51-8. 2005
    ..These findings suggest that the apical calcium channels, along with calbindin and the calcium pump, may play a role in intestinal calcium transport and its modulation by age, dietary calcium, and 1,25(OH)2D3...
  25. ncbi Hyperplasia of the parathyroid gland without secondary hyperparathyroidism
    Fumiaki Takahashi
    Renal Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA
    Kidney Int 61:1332-8. 2002
    ....
  26. ncbi Calcium-sensing receptor expression is regulated by glial cells missing-2 in human parathyroid cells
    Masahide Mizobuchi
    Renal Division, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Bone Miner Res 24:1173-9. 2009
    ..05) by Gcm2 silencing. Exon 1A-containing transcripts from promoter 1 were expressed at very low levels in the cultures. These results indicate that one function of Gcm2 is to maintain high levels of CaR expression in parathyroid cells...
  27. ncbi Vitamin D
    Adriana S Dusso
    Renal Division, Washington University School of Medicine, St Louis, MO 63110 1093, USA
    Am J Physiol Renal Physiol 289:F8-28. 2005
    ..This local production of 1,25(OH)(2)D(3) is dependent on circulating precursor levels, providing a potential explanation for the association of vitamin D deficiency with various cancers and autoimmune diseases...
  28. ncbi Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion
    Alex J Brown
    Washington University School of Medicine, 660S Euclid Avenue, Box 8126, St. Louis, Missouri 63110, USA
    J Cell Biochem 96:569-78. 2005
    ..5 mg/dl) was nearly 80 times higher. These findings indicate that 1alphaOH-3-epi-D3 is a highly selective vitamin D analog with tremendous potential for treatment of secondary hyperparathyroidism in chronic renal failure patients...
  29. ncbi Acute regulation of parathyroid hormone by dietary phosphate
    Daniel R Martin
    Renal Division, Washington University School of Medicine, St. Louis, MO 63110, USA
    Am J Physiol Endocrinol Metab 289:E729-34. 2005
    ..These findings indicate that oral P(i) increases PTH release in vivo more rapidly than previously reported; this response may be from both plasma phosphate and an additional signal arising from the gastrointestinal tract...
  30. ncbi Oral feeding acutely down-regulates serum PTH in hemodialysis patients
    Alex J Brown
    Renal Division, Department of Internal Medicine, Chromalloy American Kidney Center at Washington University School of Medicine, St. Louis, MO, USA
    Nephron Clin Pract 103:c106-13. 2006
    ..This effect is not mediated by changes in ionized calcium, phosphorus, pH, glucose, or insulin. These data suggest there may be an as yet unknown enteral signal that rapidly suppresses PTH...
  31. ncbi FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation
    Sangeeta Pande
    Renal Division, Washington University School of Medicine, St. Louis, Mo. 63110, USA
    Nephron Physiol 104:p23-32. 2006
    ..Residual FGF-23 may contribute to the hypophosphatemia in post-transplant patients...
  32. ncbi Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function
    Cynthia S Ritter
    Renal Division, Washington University School of Medicine, St Louis, Missouri, USA
    J Bone Miner Res 17:2206-13. 2002
    ..We conclude that although phosphate restriction restores CaR expression and function in parathyroid glands of uremic rats, it is a late event and not involved in the arrest of secondary HPT...
  33. ncbi Tissue distribution and activity studies of 1,24-dihydroxyvitamin D2, a metabolite of vitamin D2 with low calcemic activity in vivo
    Alex J Brown
    Renal Division, Washington University School of Medicine, St. Louis, MO, USA
    Biochem Pharmacol 68:1289-96. 2004
    ..Further studies will be necessary to confirm these findings and to confirm the clinical utility of 1,24(OH)(2)D(2)...
  34. ncbi Parathyroid cells cultured in collagen matrix retain calcium responsiveness: importance of three-dimensional tissue architecture
    Cynthia S Ritter
    Renal Division, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Bone Miner Res 19:491-8. 2004
    ....
  35. ncbi Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model
    Richard J Lund
    Renal Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA
    J Am Soc Nephrol 15:359-69. 2004
    ..05). ABD produced in mice with CKD in the absence of hyperparathyroidism was successfully reversed with a bone anabolic, BMP-7, associated with a reduction in plasma phosphorus...
  36. ncbi 2,2-Disubstituted analogues of the natural hormone 1 alpha,25-dihydroxyvitamin D(3): chemistry and biology
    Gary H Posner
    Department of Chemistry, Krieger School of Arts and Sciences, The Johns Hopkins University, Baltimore, MD 21218, USA
    Bioorg Med Chem 10:2353-65. 2002
    ..Dimethylated analogue strongly suppresses parathyroid hormone (PTH) secretion...